Iressa 250 mg

IRESSA 250 MG tablets contain gefitinib, a medication used to manage certain types of cancer. This oral treatment is designed to target specific cancer cells, offering a targeted approach to therapy. Learn more about gefitinib and its uses here.

IRESSA 250 MG tablets are primarily used in the treatment of specific types of cancer. Gefitinib, the active ingredient, is often prescribed for non-small cell lung cancer (NSCLC) that has spread or returned. This medication works by targeting certain proteins in cancer cells, which can help slow down the growth and spread of the disease. Patients should consult their healthcare provider to determine if gefitinib is suitable for their condition.

Common effects of IRESSA 250 MG tablets may include skin rash, diarrhea, and nausea. Some users might experience appetite loss or dry skin. These effects can vary from person to person, and not everyone will experience them. If any side effects are severe or persistent, it is important to seek medical advice.

IRESSA 250 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may interact with other treatments, so it is crucial to inform your doctor about all medications you are taking. Pregnant or breastfeeding women should consult their healthcare provider before using gefitinib.

IRESSA 250 MG tablets may interact with certain medications, including those that affect liver enzymes. It is important to avoid grapefruit or grapefruit juice while taking gefitinib, as it can increase the risk of side effects. Always inform your healthcare provider about all medications, supplements, and herbal products you are using to avoid potential interactions.